Paul Tudor Jones's IBB Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 8,963 shares of iShares Biotechnology ETF (IBB) worth $1.51 M, representing 0.00% of the portfolio. First purchased in 2016-Q4, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in IBB, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2017, adding 78,000 shares. Largest reduction occurred in Q1 2017, reducing 100,000 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's iShares Biotechnology ETF (IBB) Holding Value Over Time
Track share changes against reported price movement
Quarterly iShares Biotechnology ETF (IBB) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2,513 | Add 38.96% | 8,963 | $168.77 |
| Q3 2025 | +6,450 | New Buy | 6,450 | $144.37 |
| Q2 2025 | -1,723 | Sold Out | 0 | $0.00 |
| Q1 2025 | +1,723 | New Buy | 1,723 | $127.90 |
| Q4 2024 | -9,423 | Sold Out | 0 | $0.00 |
| Q3 2024 | -2,634 | Reduce 21.85% | 9,423 | $145.60 |
| Q2 2024 | +12,057 | New Buy | 12,057 | $137.26 |
| Q1 2024 | -8,224 | Sold Out | 0 | $0.00 |
| Q4 2023 | +8,224 | New Buy | 8,224 | $135.85 |
| Q1 2022 | -1,465 | Sold Out | 0 | $0.00 |
| Q4 2021 | +1,465 | New Buy | 1,465 | $152.90 |
| Q3 2021 | -2,166 | Sold Out | 0 | $0.00 |
| Q2 2021 | +2,166 | New Buy | 2,166 | $163.43 |
| Q3 2017 | -78,000 | Sold Out | 0 | $0.00 |
| Q2 2017 | +78,000 | New Buy | 78,000 | $310.08 |
| Q1 2017 | -100,000 | Sold Out | 0 | $0.00 |
| Q4 2016 | +100,000 | New Buy | 100,000 | $265.38 |
Paul Tudor Jones's iShares Biotechnology ETF Investment FAQs
Paul Tudor Jones first purchased iShares Biotechnology ETF (IBB) in Q4 2016, acquiring 100,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held iShares Biotechnology ETF (IBB) for 17 quarters since Q4 2016.
Paul Tudor Jones's largest addition to iShares Biotechnology ETF (IBB) was in Q4 2016, adding 100,000 shares worth $26.54 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 8,963 shares of iShares Biotechnology ETF (IBB), valued at approximately $1.51 M.
As of the Q4 2025 filing, iShares Biotechnology ETF (IBB) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in iShares Biotechnology ETF (IBB) was 100,000 shares, as reported at the end of Q4 2016.